The best advice for cooks  

New advances in the treatment of genitourinary, gastrointestinal and gynecologic cancers were released at a press briefing at the 46th Annual Meeting of the American Society of Clinical Oncology (ASCO). “We had hoped we could use cetuximab in a targeted w…

The rest is here:
Studies Report Progress Against Genitourinary, Gastrointestinal And Gynecologic Cancers (source: Medical News Today)

The Alabama Department of Public Health has conducted an epidemiological investigation into the reports of illness among recent visitors to Oak Mountain State Park. Based on the results of the investigation, the outbreak occurred among visitors to the pa…

See the rest here: 
ADPH Releases Findings On Illnesses Linked To Oak Mountain State Park (source: Medical News Today)

A widely used anticonvulsant may hold promise for the treatment of α1-antitrypsin deficiency, the most common genetic cause of liver disease in children, researchers said. (source: medpagetoday.com) - Share on Twitter - Share on Facebook - RSS feeds and Widgets on Feedzilla.com

Read the original post: 
Well-Known Drug May be Useful in Liver Disease (CME/CE) (source: medpagetoday.com)

Orexigen® Therapeutics, Inc. (Nasdaq: OREX), a biopharmaceutical company focused on the treatment of obesity, announced that the U.S. Food and Drug Administration (FDA) has accepted for filing the Company’s New Drug Application (NDA) for Contrave® (naltrex…

More here:
Orexigen® Therapeutics Announces FDA Acceptance Of Contrave® New Drug Application For The Treatment Of Obesity (source: Medical News Today)

Albireo announced that additional clinical data will be reported from a recent study assessing the safety, tolerability and efficacy of A3309 in patients with chronic constipation. A3309 is a first-in-class investigational compound for the treatment of irr..

See the original post here:
Albireo Announces Positive Results From A Study With A3309 In Patients With Chronic Constipation (source: Medical News Today)

Muscle degeneration and confinement to a wheelchair are the hallmarks of Lou Gehrig’s disease, Parkinson’s, muscular dystrophy and other neurodegenerative diseases. One of the silent, and most serious, symptoms of these diseases is losing the ability to sw… (source: Medical News Today) - Share on Twitter - Share on Facebook - RSS and RSS Feed on Feedzilla.com

Read the original post:
Developing Test For Swallowing Disorder Treatments Could Lead To Treatment For Lou Gehrig’s Patients (source: Medical News Today)

Johnson & Johnson Pharmaceutical Research and Development (J&JPRD) announced that the U.S. Food and Drug Administration (FDA) has approved a new drug application (NDA) for PANCREAZET (pancrelipase) delayed-release capsules for the treatment of exocrine pan… (source: Medical News Today) - Share on Twitter - Share on Facebook - RSS news feeds and Widgets on Feedzilla.com

Excerpt from:
FDA Approves New Drug Application For PANCREAZE(TM) (source: Medical News Today)

Orexigen® Therapeutics, Inc. (Nasdaq: OREX) announced that the Company has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for Contrave® (naltrexone SR/bupropion SR), its investigational drug for the treatment of obesi…

Here is the original post: 
Orexigen(R) Therapeutics Submits Contrave(R) New Drug Application To FDA For The Treatment Of Obesity (source: Medical News Today)

Older colon cancer patients tended to undergo milder chemotherapy regimes after surgery than younger patients, with fewer adverse events, but they may not have reaped the full benefits of the treatment, researchers found. (source: medpagetoday.com) - News widgets and RSS feeds on Feedzilla.com

See more here:
Chemo Use Spotty in Older Colon Cancer Patients (CME/CE) (source: medpagetoday.com)

An increased dosage of Tamiflu (oseltamivir) for patients with critical illness is unlikely to be required in the treatment of pandemic (H1N1) influenza, contrary to current international guidelines, found a new study http://www.cmaj.ca/cgi/doi/10.1503/cma… (source: Medical News Today) - RSS and News widget on Feedzilla.com

Excerpt from:
Critically Ill Patients With H1N1 And Gastrointestinal Absorption Of Tamiflu (source: Medical News Today)